Trial Profile
RELATE and PREDICT TRD: A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminergic reward-learning signals and prediction of clinical (non-) response in Major Depressive Disorder.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Nortriptyline (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms RELATE-TRD
- 28 Jan 2014 New source identified and integrated (European Clinical Trials Database; EudraCT2013-001818-14).
- 15 May 2013 New trial record